DRRX
Closed
Durect Corporation
0.64
0.00 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.6352
Day's Range: 0.6399 - 0.6651
Send
sign up or login to leave a comment!
When Written:
4.53
Durect Corporation is a biopharmaceutical company that develops and commercializes innovative therapies for the treatment of chronic diseases. The company's proprietary drug delivery technologies enable the development of therapies that are designed to improve the safety, efficacy, and convenience of existing drugs, as well as to create new drugs with improved properties.
Durect's portfolio of products includes drugs for the treatment of chronic pain, postoperative pain, and chemotherapy-induced nausea and vomiting. The company also has several drug candidates in development for the treatment of liver disease, inflammatory diseases, and other conditions.
Durect was founded in 1998 and is headquartered in Cupertino, California. The company is publicly traded on the NASDAQ exchange under the ticker symbol DRRX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Durect's portfolio of products includes drugs for the treatment of chronic pain, postoperative pain, and chemotherapy-induced nausea and vomiting. The company also has several drug candidates in development for the treatment of liver disease, inflammatory diseases, and other conditions.
Durect was founded in 1998 and is headquartered in Cupertino, California. The company is publicly traded on the NASDAQ exchange under the ticker symbol DRRX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








